MARTA MORRISSETTE: Open Payments
NPI 1598016388 · DARTMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 59 payments from 17 companies in 2025. Trend: 2023 $1,202 · 2024 $1,007 · 2025 $1,516
Food & beverage: $1,516
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $261 |
| Actelion Pharmaceuticals US, Inc. | 4 | $191 |
| Novo Nordisk Inc | 6 | $175 |
| Amgen Inc. | 7 | $136 |
| BridgeBio Pharma, Inc. | 4 | $119 |
| Abbott Laboratories | 2 | $113 |
| Alnylam Pharmaceuticals Inc. | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $88 |
| PFIZER INC. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
Products named: CAMZYOS, Wegovy, UPTRAVI, Attruby, Repatha, AMPLATZER AMULET, ELIQUIS, JARDIANCE.
Industry payments across MA — which companies pay providers there.
